Renal Resistive Index Is Associated With Inactive Matrix Gla (γ‐Carboxyglutamate) Protein in an Adult Population‐Based Study

Autor: David A. Jaques, Edward Pivin, Menno Pruijm, Daniel Ackermann, Idris Guessous, Georg Ehret, Fang‐Fei Wei, Jan A. Staessen, Antoinette Pechère‐Bertschi, Cees Vermeer, Bruno Vogt, Michel Burnier, Pierre‐Yves Martin, Murielle Bochud, Belen Ponte

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 18 (2019)

Background Increased renal resistive index (RRI) has been associated with target organ damage as well as renal and cardiovascular outcomes. Matrix Gla (γ‐carboxyglutamate) protein (MGP) is a strong inhibitor of soft tissue calcification. Its inact

Externí odkaz: https://doaj.org/article/907f47f4b2bd4b3c8b15cafd52972522

Renal Resistive Index Is Associated With Inactive Matrix Gla (γ-Carboxyglutamate) Protein in an Adult Population-Based Study.

Autor: Jaques DA; Division of Nephrology Geneva University Hospitals Geneva Switzerland., Pivin E; Division of Chronic Disease University Institute of Social and Preventive Medicine Lausanne University Hospital Lausanne Switzerland., Pruijm M; Division of Nephrology and Hypertension Lausanne University Hospital and University of Lausanne Lausanne Switzerland., Ackermann D; University Clinic for Nephrology, Hypertension and Clinical Pharmacology Bern University Hospital Bern Switzerland., Guessous I; Division of Primary Care Medicine Department of Primary Care Medicine Geneva University Hospitals Geneva Switzerland., Ehret G; Division of Cardiology Geneva University Hospitals Geneva Switzerland., Wei FF; Studies Coordinating Centre Research Unit of Hypertension and Cardiovascular Epidemiology KU Leuven Department of Cardiovascular Sciences University of Leuven Belgium., Staessen JA; Studies Coordinating Centre Research Unit of Hypertension and Cardiovascular Epidemiology KU Leuven Department of Cardiovascular Sciences University of Leuven Belgium., Pechère-Bertschi A; Division of Hypertension Geneva University Hospitals Geneva Switzerland., Vermeer C; R&D Group VitaK Maastricht University Maastricht The Netherlands., Vogt B; University Clinic for Nephrology, Hypertension and Clinical Pharmacology Bern University Hospital Bern Switzerland., Burnier M; Division of Nephrology and Hypertension Lausanne University Hospital and University of Lausanne Lausanne Switzerland., Martin PY; Division of Nephrology Geneva University Hospitals Geneva Switzerland., Bochud M; Division of Chronic Disease University Institute of Social and Preventive Medicine Lausanne University Hospital Lausanne Switzerland., Ponte B; Division of Nephrology Geneva University Hospitals Geneva Switzerland.; Division of Chronic Disease University Institute of Social and Preventive Medicine Lausanne University Hospital Lausanne Switzerland.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2019 Sep 17; Vol. 8 (18), pp. e013558. Date of Electronic Publication: 2019 Sep 12.